Goldsmith Mark A Insider Trades & Stock Holdings

President and Chief Executive Officer · Revolution Medicines, Inc. · Latest filing Sep 16, 2026

Goldsmith Mark A, President and Chief Executive Officer at Revolution Medicines, Inc. has 1 Form 4 trade on file since Sep 16, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($2.79M), net -$2.79M. Latest filing: disposed of 13.99K shares of $RVMD on Sep 16, 2026 at $199.24.

Trades on file

1

Open-market bought

$0

Open-market sold

$2.79M

Net open-market

-$2.79M

Latest filing

Sep 16, 2026

All insider trades by Goldsmith Mark A

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 16, 2026	$RVMD	Sell (Open-market sale) 10b5-1	13.99K	$199.24	$2.79M			-2.6%	-9.2%		President and Chief Executive Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Goldsmith Mark A traded

• $RVMD

Frequently asked questions

Has Goldsmith Mark A been buying or selling stock?

Goldsmith Mark A has 0 open-market purchases and 1 open-market sale on file, net -$2.79M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Goldsmith Mark A's latest insider trade?

disposed of 13.99K shares of $RVMD on Sep 16, 2026 at $199.24.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.